Tango Therapeutics, Inc.
TNGX
Classement en actions
#4540
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Prix de l'action
$27.18
Dernière synchronisation: 2026-07-31
Capitalisation boursière
$3.38B
Changement (1 jour)
-1.41%
Changement (1 an)
202.34%
Pays
US
Échange Tango Therapeutics, Inc. (TNGX)
Catégorie
Healthcare
Nombre d'actions en circulation pour Tango Therapeutics, Inc. (TNGX)
Nombre d'actions en circulation au June 2026: 149.88M
Selon les derniers rapports financiers et le cours de l'action de Tango Therapeutics, Inc., le nombre actuel d'actions en circulation est de 149.88M. À la fin de December 2023, l'entreprise avait 94.57M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Tango Therapeutics, Inc. (TNGX) de 2019 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 149.88M | 37.22% |
| 2024 | 109.23M | 15.50% |
| 2023 | 94.57M | 7.69% |
| 2022 | 87.82M | 41.40% |
| 2021 | 62.11M | -29.00% |
| 2020 | 87.47M | 0.00% |
| 2019 | 87.47M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 69.41% |
US
|
|
| 396.00M | 164.22% |
US
|
|
| 478.91M | 219.54% |
AU
|
|
| 62.19M | -58.51% |
NL
|
|
| - | - |
CH
|
